Overexpression of FGFR2 contributes to inherent resistance to MET inhibitors in MET-amplified patient-derived gastric cancer xenografts

Kai Liu(Shandong Tumor Hospital), Heng Ma(Chinese Academy of Medical Sciences & Peking Union Medical College)
Oncology Letters
August 12, 2015
Cited by 12


Related Papers